NCT04701801

Brief Summary

Breast cancer is the most common type of cancer in women. Anxiety and depression often accompany the treatment phase of oncology patients. Since both anxiety and depression are associated with increased inflammatory activity, these preoperative symptoms may predispose patients to the development of postoperative neurocognitive dysfunction. The aim of this study is to reveal the correlation of preoperative anxiety with early postoperative cognitive dysfunction in patients with breast cancer who will undergo surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 21, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 8, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2021

Completed
Last Updated

November 2, 2022

Status Verified

October 1, 2022

Enrollment Period

7 months

First QC Date

January 5, 2021

Last Update Submit

October 31, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determining the preoperative anxiety level and evaluating the difference between the preoperative moca test and the moca test performed on the postoperative 7th day (early period)

    The researcher will perform the neurocognitive level with a face-to-face interview with the moca test before surgery. In the postoperative period, the test will be repeated on the 7th day. If the moca test is above 21, it will be considered normal. and the patient will be enrolled. A decrease of 4 units in the moca test on the 7th postoperative day will be considered as postoperative cognitive dysfunction.

    7th postoperative day

Interventions

MoCA testDIAGNOSTIC_TEST

Preoperative MoCA test and State-Trait Anxiety Inventory Test (STAI FORM ) questionnaire form will be filled in female patients between the ages of 18-65 by making a one-on-one interview with the patient and the MoCA test will be applied in the early postoperative period (1st week) to ensure its relationship with POCD will be checked.

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe preoperative anxiety rate was found twice as high in female patients compared to male patients.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female patients aged 18-65 years who are scheduled for elective surgery due to breast malignancy who meet the inclusion criteria

You may qualify if:

  • Should be female
  • Should be between 18-65 years old
  • Diagnosed with breast cancer
  • Scoring 21 or above in the MoCA test,
  • Patients under general anesthesia
  • Are decided to have Total Mastectomy, Modified Radical Mastectomy or Breast Conserving surgery
  • Having a risk score of The American society of Anesthesiologists (ASA) risk score 3 and below

You may not qualify if:

  • Cerebral ischemia or hemorrhage history
  • Clinical diagnosis of Neurodegenerative disease
  • Clinical diagnosis of carotid stenosis,
  • The score 20 or less in the Moca test,
  • Carotid endarterectomy history
  • Aneurysm surgery history
  • Alcohol addiction
  • Clinical diagnosis of psychiatric disease
  • Cervical surgery history
  • Inability to comply with the questionnaire or study
  • Chemotherapy history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr.Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital clinic of Anesthesiology and Reanimation

Ankara, Turkey (Türkiye)

Location

Related Publications (5)

  • Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012 Dec 10;141(2-3):343-51. doi: 10.1016/j.jad.2012.03.025. Epub 2012 Jun 21.

    PMID: 22727334BACKGROUND
  • Alam A, Hana Z, Jin Z, Suen KC, Ma D. Surgery, neuroinflammation and cognitive impairment. EBioMedicine. 2018 Nov;37:547-556. doi: 10.1016/j.ebiom.2018.10.021. Epub 2018 Oct 19.

    PMID: 30348620BACKGROUND
  • Peng L, Xu L, Ouyang W. Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis. PLoS One. 2013 Nov 13;8(11):e79624. doi: 10.1371/journal.pone.0079624. eCollection 2013.

    PMID: 24236147BACKGROUND
  • Camacho A. Is anxious-depression an inflammatory state? Med Hypotheses. 2013 Oct;81(4):577-81. doi: 10.1016/j.mehy.2013.07.006. Epub 2013 Jul 26.

    PMID: 23891039BACKGROUND
  • Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JS, Speca M, Tillotson L, Bultz BD. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004 Jun 14;90(12):2297-304. doi: 10.1038/sj.bjc.6601887.

    PMID: 15162149BACKGROUND

MeSH Terms

Conditions

Postoperative Cognitive Complications

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
8 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research assistant

Study Record Dates

First Submitted

January 5, 2021

First Posted

January 8, 2021

Study Start

October 21, 2020

Primary Completion

May 31, 2021

Study Completion

July 13, 2021

Last Updated

November 2, 2022

Record last verified: 2022-10

Locations